TY  - JOUR
AU  - Herrera-Hidalgo, Laura
AU  - Lomas-Cabezas, Jose Manuel
AU  - Lopez-Cortes, Luis Eduardo
AU  - Luque-Marquez, Rafael
AU  - Lopez-Cortes, Luis Fernando
AU  - Martinez-Marcos, Francisco J
AU  - de-la-Torre-Lima, Javier
AU  - Plata-Ciezar, Antonio
AU  - Hidalgo-Tenorio, Carmen
AU  - Garcia-Lopez, Maria Victoria
AU  - Vinuesa, David
AU  - Gutierrez-Valencia, Alicia
AU  - Gil-Navarro, Maria Victoria
AU  - De-Alarcon, Aristides
PY  - 2021
DO  - 10.3390/jcm11010007
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/21221
T2  - Journal of clinical medicine
AB  - Ampicillin plus ceftriaxone (AC) is a well-recognized inpatient regimen for Enterococcus faecalis infective endocarditis (IE). In this regimen, ceftriaxone is usually administered 2 g every 2 h (AC12). The administration of AC in outpatient parenteral...
LA  - en
PB  - MDPI
KW  - Enterococcus faecalis
KW  - Ampicillin
KW  - Ceftriaxone
KW  - Infective endocarditis
KW  - Outpatient parenteral antibiotic treatment
KW  - Anti-Bacterial Agents
KW  - Ceftriaxone
KW  - Inpatients
KW  - Retrospective Studies
KW  - Patient Readmission
KW  - Ampicillin
TI  - Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT.
TY  - research article
VL  - 11
ER  -